RT Book, Section
A1 Kao, Christina
A1 Li, Gloria
A1 Parulekar, Amit
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Burt, Bryan M.
A2 Groth, Shawn S.
A2 Loor, Gabriel
A2 Wolf, Andrea S.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1170413555
T1 Medical Management of Lung Transplant Patients
T2 Sugarbaker’s Adult Chest Surgery, 3e
YR 2020
FD 2020
PB McGraw-Hill Education
PP New York, NY
SN 9781260026931
LK accesssurgery.mhmedical.com/content.aspx?aid=1170413555
RD 2024/04/18
AB Successful  medical  management  of  the  lung  transplant  patient  requires  manipulation  of  the  immune  system  to  prevent  graft  rejection  while  avoiding  an  increased  risk  for  infection.  This  balance  between  rejection  and  infection  is  a  key  determinant  of  the  long-term  survival  of  these  patients.  The  pharmacologic  management  of  lung  transplant  recipients  varies  by  institution,  and  the  optimal  regimen  has  not  yet  been  defined.  Currently,  a  variety  of  induction  and  maintenance  regimens  are  used.1